Pharmacogenet Genomics. 2011 Jul;21(7):440-6. doi: 10.1097/FPC.0b013e32833ffb56.

Doxorubicin pathways: pharmacodynamics and adverse effects.

Thorn CF, Oshiro C, Marsh S, Hernandez-Boussard T, McLeod H, Klein TE, Altman RB.

Source

Departments of Genetics, Stanford University Medical Center, California 94305-5120, USA.

PMID:: 21048526; [PubMed - indexed for MEDLINE]
PMCID:: PMC3116111

Free PMC Article

Images from this publication.See all images (2)Free text

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

Research Support, N.I.H., Extramural

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Molecular Biology Databases

Supplemental Content

Save items

Click here to read article using PubReader

Related citations in PubMed

How could we solve the diagnostic dilemma of doxorubicin toxicity in high-risk patients? [J Natl Med Assoc. 2004]
How could we solve the diagnostic dilemma of doxorubicin toxicity in high-risk patients?
Davutoglu V, Soydinc S, Akdemir I. J Natl Med Assoc. 2004 May; 96(5):689-90.
Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil. [J Pharm Pharm Sci. 2007]
Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
Wu J, Lu Y, Lee A, Pan X, Yang X, Zhao X, Lee RJ. J Pharm Pharm Sci. 2007; 10(3):350-7.
cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways. [J Pharmacol Exp Ther. 2001]
cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways.
Watts GS, Futscher BW, Isett R, Gleason-Guzman M, Kunkel MW, Salmon SE. J Pharmacol Exp Ther. 2001 Nov; 299(2):434-41.
Review Pharmacogenetics of target genes across doxorubicin disposition pathway: a review. [Curr Drug Metab. 2010]
Review Pharmacogenetics of target genes across doxorubicin disposition pathway: a review.
Lal S, Mahajan A, Chen WN, Chowbay B. Curr Drug Metab. 2010 Jan; 11(1):115-28.
Review [Inhibition of hydrogen peroxide, oxygen and semiquinone radicals in the development of drug resistance to doxorubicin in human erythroleukemia K562-cells]. [Vopr Onkol. 2003]
Review [Inhibition of hydrogen peroxide, oxygen and semiquinone radicals in the development of drug resistance to doxorubicin in human erythroleukemia K562-cells].
Kalishina EV, Saprin AN, Solomka VS, Shchebrak NP, Piruzian LA. Vopr Onkol. 2003; 49(3):294-8.

See reviews... See all...

Cited by 3 PubMed Central articles

Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization. [BMC Cancer. 2012]
Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization.
Heibein AD, Guo B, Sprowl JA, Maclean DA, Parissenti AM. BMC Cancer. 2012 Aug 31; 12:381. Epub 2012 Aug 31.
Review Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: mechanisms and implications. [Nitric Oxide. 2012]
Review Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: mechanisms and implications.
Xi L, Zhu SG, Das A, Chen Q, Durrant D, Hobbs DC, Lesnefsky EJ, Kukreja RC. Nitric Oxide. 2012 May 15; 26(4):274-84. Epub 2012 Apr 5.
PharmGKB summary: very important pharmacogene information for G6PD. [Pharmacogenet Genomics. 2012]
PharmGKB summary: very important pharmacogene information for G6PD.
McDonagh EM, Thorn CF, Bautista JM, Youngster I, Altman RB, Klein TE. Pharmacogenet Genomics. 2012 Mar; 22(3):219-28.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Doxorubicin pathways: pharmacodynamics and adverse effects.
Doxorubicin pathways: pharmacodynamics and adverse effects.
Pharmacogenet Genomics. 2011 Jul ;21(7):440-6. doi: 10.1097/FPC.0b013e32833ffb56.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: